Periodic Reporting for period 4 - iLCA (Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies)

The development and manufacture of all Biologic drugs requires a highly productive cell line to produce these drugs, the generation of which is a complex multi-step process referred to as Cell Line Development (CLD). CLD processes are resource intensive and require lengthy...